OakChart

DSS Inc

DSSConsumer Cyclical·Packaging & Containers·USA·Nano·AMEX·Nov 10 • 3:57 PM ET

0.45200.0000 (0.00%)
2026-11-11 14:56 CET
Market cap
4.54 USD m
Revenue, TTM
18.45 USD m
Net income, TTM
-27.65 USD m
Free cash flow, TTM
-11.92 USD m
EPS diluted, TTM
-2.95
P/E
-
Compare

Price

DSS against its 20, 50 and 200-day averages
2050200earnings
0.400.600.801.001.2055.3M110.5MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26DSSclose 0.4520-day 0.5350-day 0.62200-day 0.690.45

75.7% under 1.86 on 2 Feb 2026. Last 15 sessions, 29.1% high to low

Profile

DSS
52-week range, 6% of the way up
0.361.86

DSS, Inc. engages in the development and distribution of paper products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. It operates through the following segments: Product Packaging, Commercial Lending, Biotechnology, Direct Marketing, and Securities and Investment Management. The Product Packaging segment operates in the paper board folding carton, smart packaging, and document security printing markets. The Commercial Lending segment provides commercial loans and on acquiring equity positions in undervalued commercial bank(s), bank holding companies and non-banking licensed financial companies operating in the United States, Southeast Asia, Taiwan, Japan, and South Korea. The Biotechnology segment invests in or acquires companies in the bio-health and bio-medical fields, including businesses focused on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. The Direct Marketing segment provides services to assist companies in the emerging growth big business model of peer-to-peer decentralized sharing marketplaces. The Securities and Investment Management segment develops and acquires assets and investments in the securities trading and funds management arena and to pursue, among other product and service lines, real estate investment funds, broker dealers and mutual funds management. The company was founded in May 1984 and is headquartered in West Henrietta, NY.

Employees102
IPOApr 08, 1994
Beta1.06
ATR, 14d0.04
Rel volume0.00
Short float0.48%
Insider own59.71%
Inst own4.25%

Snapshot

6 groups

Valuation

Index-
Market Cap4.54M
Enterprise Value51.35M
Income-27.65M
Sales18.45M
Book/sh-0.04
Cash/sh0.51
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees102
IPOApr 08, 1994

Ratios

P/E-
Forward P/E-
PEG-
P/S0.25
P/B-
P/C0.88
P/FCF-
EV/EBITDA-
EV/Sales2.78
Quick Ratio0.15
Current Ratio0.19
Debt/Eq-
LT Debt/Eq-
Option/ShortNo / Yes

Earnings

EPS (ttm)-2.95
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y37.15% -
Sales past 3/5Y-24.01% 6.20%
EPS Y/Y TTM52.19%
Sales Y/Y TTM-13.17%
EPS Q/Q-101.48%
Sales Q/Q-31.81%
EarningsMay 19
EPS/Sales Surpr.-326.32% -19.61%

Ownership

Insider Own59.71%
Insider Trans-0.36%
Inst Own4.25%
Inst Trans13.16%
ROA-34.19%
ROE-361.77%
ROIC-269.07%
Gross Margin-20.80%
Oper. Margin-89.83%
Profit Margin-149.84%
SMA20-14.31%
SMA50-27.62%
SMA200-34.04%
Trades-

Technical

Shs Outstand10.04M
Shs Float4.05M
Short Float0.48%
Short Ratio0.01
Short Interest0.02M
52W High1.86 -75.70%
52W Low0.36 25.38%
Volatility12.72% 7.01%
ATR (14)0.04
RSI (14)32.81
Beta1.06
Rel Volume0.00
Avg Volume1.90M
Volume0

Performance

Perf Week-11.89%
Perf Month-24.95%
Perf Quarter-11.93%
Perf Half Y-15.55%
Perf YTD-51.28%
Perf Year-62.33%
Perf 3Y-83.86%
Perf 5Y-97.88%
Perf 10Y-99.82%
Recom1.00
Target Price3.00
Prev Close0.45
Price0.45
Change %0.00%

Analyst ratings

latest 2 of 2
DateActionAnalystRating changeTargetImplied
Jun 24, 2020InitiatedAAegis CapitalBuy$14+2,997.3%
Jul 22, 2013InitiatedDDawson JamesBuy$4+785.0%

Peers

Mkt cap
TickerCompanyMkt cap
GPKGraphic Packaging Holding Co3.33B
MGIHMillennium Group International Holdings Ltd14.40M
YHGJYunhong Green CTI Ltd8.74M
PACKRanpak Holdings Corp302.83M
GEFGreif Inc4.00B
KRTKarat Packaging Inc755.96M
TRSTrimas Corp1.35B
MYEMyers Industries Inc1.05B
AMBPArdagh Metal Packaging SA2.83B
OIO-I Glass Inc808.53M

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Chan Heng Fai AmbroseDirectorSep 03 '26Sale0.8221,85217,9191,031,944Sep 08 05:20 PM

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 206
  • DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination (ACCESSWIRE)
  • DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical's Proposed Business Combination with Zoar Limited (GlobeNewswire)
  • DSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise Operations (GlobeNewswire)
  • DSS Shares Crash After Soaring. What the New Offering Means for Investors (GuruFocus.com)
  • DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offering (GlobeNewswire)
  • Loading…
  • DSS, Inc. Announces Launch of Proposed Public Offering (GlobeNewswire) +53.99%
  • DSS, Inc. Withdraws Registration Statement (GlobeNewswire) +19.55%
  • DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing (GlobeNewswire)
  • DSS, Inc. Letter to Shareholders (GlobeNewswire) +10.94%
  • Impact Biomedical (IBO) Stock Jumps Over 86% After Hours - Here's Why (Benzinga)
  • DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering (GlobeNewswire) -5.31%
  • DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering (GlobeNewswire) -32.37%
  • DSS, Inc. Announces Launch of Proposed Public Offering (GlobeNewswire) +17.80%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q12026-05-19-0.600-0.600-0.6004.334.331
2025Q42026-02-25-1.620-0.380-1.6204.105.101
2025Q32025-10-27-0.250--0.2536.39--
2023Q32023-10-23-0.600-0.400-0.6194.205.751
2023Q22023-08-14-5.400-0.560-5.4127.239.901
2023Q12023-05-16-1.120-1.038-1.15611.9311.771
2022Q42023-03-31-1.212-1.600-3.87411.1012.001
2022Q32022-11-14-1.904-1.200-2.99711.9013.141
2022Q22022-09-14-0.866-1.800-1.02411.8012.632
2022Q12022-05-16-1.732-1.400-1.90212.309.982
2021Q42022-03-31-2.510-0.866-3.1287.087.501
2021Q32021-11-18-1.212-1.200-1.8544.574.422
2021Q22021-08-23-3.030-1.600-4.8264.194.542
2021Q12021-05-14-3.600-1.500-4.0974.945.19-
2020Q42021-03-31-7.000-5.000-1.6355.896.80-
2020Q32020-10-26-5.800-3.80012.9864.173.03-

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2013FY-374.06-166.1817.45-
2014FY-146.6-457-2,03618.2918.90
2015FY-623.19--2,88017.51-
2016FY43.562--42.00019.18-
2018FY90.11157.12651.91818.5218.50
2019FY-57.126-62.319-67.96219.4112.69
2020FY17.484-27.1786.31017.4018.31
2021FY-10.906-5.020-13.76120.2921.19
2022FY-8.411--10.72247.65-
2023FY-7.600-7.600-8.66629.8029.80
2025FY-2.660-1.410-2.66020.7621.73
2026FY--1.380--19.53

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q2S2026-05-191004.604.604.60
2026Q2S2026-05-181004.604.604.60
2026Q2R2026-05-19100-0.30-0.30-0.30
2026Q2R2026-05-18100-0.30-0.30-0.30
2026Q2E2026-05-19100-0.30-0.30-0.30
2026Q2E2026-05-18100-0.30-0.30-0.30
2026Q1S2026-05-181004.334.334.33
2026Q1R2026-05-18100-0.60-0.60-0.60
2026Q1E2026-05-18100-0.60-0.60-0.60
2026FYS2026-06-1310019.5319.5319.53
2026FYS2026-05-1810119.5319.5319.53
2026FYS2026-02-2510020.8020.8020.80
2026FYS2025-11-2110020.8020.8020.80
2026FYR2026-06-13100-1.38-1.38-1.38

Estimate history

EPS, annual-2451.918-67.9626.31-13.761-10.722-8.666-6.631-2.661-2.9544
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.663-0.748-4.645-0.55-0.237-0.253-1.622-0.603-0.477
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual18.66218.51515.5515.36620.27547.30725.93319.09720.75718.45
Period201720182019202020212022202320242025TTM
Sales, quarterly4.2115.5995.4164.9545.2856.3924.1274.3313.604
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0.0280.0290.060.2923.9876.9517.0138.0939.09310.043
Period201720182019202020212022202320242025MRQ
Shares, quarterly7.0677.0678.0939.0939.0939.0939.09310.04310.043
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue18.4520.7619.1025.9347.3120.2715.3715.5518.52
Cost of Goods Sold Incl. D&A22.2922.9323.5425.3938.3416.8212.0811.4913.14
Gross Profit-3.84-2.17-4.440.548.973.453.294.065.38
Selling, General and Administrative Excl. Other12.7412.2741.8455.1252.6626.9814.726.677.09
Research and Development0.280.340.281.691.261.080.210.010.15
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-16.58-14.43-46.29-54.57-43.69-23.53-11.43-2.62-1.71
Interest Expense0.240.270.280.552.910.200.190.130.19
Unusual Expense2.503.237.8519.4227.8211.92-11.230.00-3.37
Net Income Before Taxes-30.95-27.49-53.70-74.04-69.49-40.200.29-2.721.48
Income Taxes0.070.000.010.000.17-4.03-1.77-0.120.02
Consolidated Net Income-31.02-27.49-53.71-74.04-69.66-36.172.06-2.601.46
Net Income From Continuing Operations-27.65-23.93-46.90-57.15-59.84-35.252.54-2.601.46
Net Income-27.65-23.93-46.90-60.63-59.84-35.451.90-2.891.46
EPS (Recurring)-2.58-2.41-5.85-6.72-7.23-10.52-19.81-61,166.48-31.75
EPS (Basic, Before Extraordinaries)-2.95-2.66-6.63-8.67-10.72-13.7610.70-67.9652.55
EPS (Diluted)-2.95-2.66-6.63-8.67-10.72-13.766.31-67.9651.92
EBITDA-13.77-11.85-43.30-49.37-30.76-18.70-10.36-1.47-0.43
Non-Operating Income (Expense)-9.24-9.560.720.504.92-4.560.670.030.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.610.020.020.000.000.050.400.310.13
Price To Earnings Ratio--------7.79
Price To Sales Ratio0.320.400.330.650.391.712.440.000.67
Gross Margin-20.80-10.45-23.262.0918.9717.0221.4026.0929.06
Operating Margin-89.83-69.54-242.38-210.43-92.35-116.04-74.37-16.83-9.23
Net Margin-149.84-115.28-245.57-233.78-126.49-174.8612.36-18.587.91
Shares Outstanding10.049.098.097.016.953.990.290.060.03
Market Capitalization4.544.546.3616.8521.1647.8733.8010.1211.85

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue3.604.334.136.395.294.955.425.60
Cost of Goods Sold Incl. D&A4.525.536.176.075.505.196.276.60
Gross Profit-0.92-1.20-2.050.32-0.21-0.23-0.86-1.00
Selling, General and Administrative Excl. Other2.874.292.023.563.213.4930.234.23
Research and Development0.080.050.110.050.070.240.230.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-3.79-5.49-4.07-3.23-3.42-3.73-31.09-5.23
Interest Expense0.090.040.070.040.120.030.040.05
Unusual Expense0.830.831.91-1.07-0.960.936.830.45
Net Income Before Taxes-5.04-6.35-17.33-2.23-2.61-5.36-37.77-5.70
Income Taxes0.000.000.070.000.00-0.070.170.00
Consolidated Net Income-5.04-6.35-17.40-2.23-2.61-5.30-37.94-5.70
Net Income From Continuing Operations-4.79-5.82-14.74-2.30-2.15-4.78-32.86-5.28
Net Income-4.79-5.82-14.74-2.30-2.15-4.78-32.86-5.28
EPS (Recurring)-0.42-0.54-1.47-0.34-0.31-0.48-3.97-0.70
EPS (Basic, Before Extraordinaries)-0.48-0.60-1.62-0.25-0.24-0.55-4.64-0.75
EPS (Diluted)-0.48-0.60-1.62-0.25-0.24-0.55-4.64-0.75
EBITDA-3.14-4.85-3.63-2.15-2.89-3.20-30.55-4.68
Non-Operating Income (Expense)-0.330.00-8.88-0.03-0.02-0.670.180.03
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.161.440.010.000.000.00--
Price To Sales Ratio0.320.400.410.560.400.370.330.43
Gross Margin-25.39-27.75-49.585.07-4.05-4.70-15.82-17.93
Operating Margin-105.05-126.69-98.62-50.59-64.81-75.21-574.08-93.46
Net Margin-132.88-134.36-357.28-35.97-40.72-96.43-606.76-94.36
Shares Outstanding10.0410.049.099.099.099.098.097.07
Market Capitalization4.548.298.4412.278.556.136.368.97

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments9.0114.316.6219.2956.595.181.102.454.44
Short Term Receivables2.693.6512.7719.2811.983.594.212.222.03
Inventories2.002.442.827.728.261.961.371.561.65
Other Current Assets0.6546.3052.431.703.471.720.800.290.26
Total Current Assets14.3566.6974.6347.9980.3112.457.486.528.38
Net Property, Plant & Equipment27.2811.8513.6321.6118.174.284.475.014.81
Total Investments and Advances7.136.9617.6784.0382.6323.162.150.320.48
Long-Term Note Receivable0.000.130.110.925.880.540.790.000.30
Intangible Assets18.8020.6647.0591.6695.2450.323.393.343.67
Deferred Tax Assets----4.193.810.27--
Other Assets0.070.160.102.700.491.171.860.090.08
Total Assets67.63106.45153.19248.92282.7195.7320.4115.2817.73
Short Term Debt Incl. Current Port. of LT Debt31.6450.3848.4647.964.310.451.060.714.61
Accounts Payable2.602.793.655.911.921.461.491.350.73
Income Tax Payable--0.000.170.00----
Other Current Liabilities13.2511.853.4919.6521.586.971.603.364.06
Total Current Liabilities47.5065.0355.6173.6927.818.874.165.429.40
Long Term Debt11.428.7114.3718.0055.831.992.331.721.73
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities---0.044.197.310.310.170.13
Other Liabilities0.000.000.000.510.881.011.310.391.38
Total Liabilities58.9173.7469.9892.2384.5219.198.117.7112.64
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity-0.8319.9463.93125.56161.7876.5412.307.575.09
Total Shareholders Equity-0.8319.9463.93125.56161.7876.5512.307.575.09
Accumulated Minority Interest9.5512.7819.2931.1236.410.000.000.000.00
Total Equity8.7132.7283.21156.68198.1976.5512.307.575.09
Total Liabilities & Stockholders Equity67.63106.45153.19248.92282.7195.7320.4115.2817.73
Book Value Per Share-0.092.469.1218.0640.57262.32204.03260.80183.83
Tangible Book Value Per Share-2.16-0.092.414.8816.6989.88147.83145.9751.02
Full-Time Employees102100951191139310010698
Price to Book Ratio-11.880.120.180.140.240.440.821.566.05
Return on Assets-27.49-36.12-28.42-22.25-18.634.37-14.548.88-3.19
Return on Equity-246.60-111.83-60.32-36.73-29.585.72-26.1123.14-13.82
Return on Invested Capital-226.02-163.69-77.43-41.68-16.292.42-19.7415.76-8.48
Quick Ratio0.260.991.290.552.591.181.470.910.72
Current Ratio0.301.031.340.652.891.401.801.200.89

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-30.85-27.49-53.71-74.04-69.66-36.172.06-2.601.46
Depreciation3.753.532.985.2112.934.321.071.151.28
Other Funds (Non Cash)12.3013.9837.6058.4123.5422.14-11.040.53-3.18
Funds from Operations-14.79-9.98-13.12-10.42-33.16-13.74-9.69-1.04-0.43
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital3.250.854.36-8.776.214.933.49-4.30-0.96
Cash from Operating Activities-11.54-9.13-8.76-19.19-26.95-8.80-6.20-5.34-1.38
Capital Expenditures-0.38-0.31-0.27-0.82-2.80-32.39-0.32-1.32-1.10
Net Assets From Acquisitions0.000.000.000.00-1.880.000.000.000.00
Sale of Fixed Assets and Businesses6.2115.715.610.292.153.360.000.000.00
Purchase or Sale of Investments-0.812.413.029.50-18.36-80.75-10.37-1.830.00
Purchase of Investments-1.450.000.000.00-19.43-80.75-10.37-1.830.00
Sale Or Maturity of Investments0.642.413.029.501.070.000.000.000.00
Other Uses-0.050.00-0.46-1.05-0.11-12.220.00-0.830.00
Other Sources0.260.254.241.013.043.000.880.000.00
Cash from Investing Activities5.2318.0712.148.94-17.97-119.01-9.81-3.98-1.10
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.700.003.190.001.52121.7420.206.660.89
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.700.003.190.001.52121.7420.206.660.89
Proceedsfrom Stock Options0.700.003.190.001.52121.7420.206.660.89
Issuance or Reduction of Debt, Net0.20-14.06-1.75-2.426.1057.490.471.42-0.69
Change in Long Term Debt-0.30-14.56-1.75-2.426.1057.490.471.42-0.69
Issuance of Long Term Debt6.663.250.881.839.6059.441.281.590.50
Reduction of Long Term Debt-6.97-17.81-2.63-4.25-3.50-1.95-0.80-0.17-1.19
Net Financing Active Other Cash Flow0.000.000.000.000.000.00-0.58-0.110.29
Other Financing Activities Uses0.000.000.000.000.000.00-0.58-0.110.00
Cash from Financing Activities0.90-14.061.44-2.427.62179.2220.097.970.49
Net Change in Cash-5.42-5.124.82-12.68-37.3051.414.09-1.35-2.00
Free Cash Flow-11.92-9.44-9.03-20.01-29.25-23.09-6.52-6.29-2.39
Preferred Dividends (Cash Flow)-0.000.000.000.000.00-0.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.04-4.03-1.77-0.120.01

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments5.165.929.018.7812.4610.97
Short Term Receivables1.762.472.694.592.993.17
Inventories1.981.822.002.872.542.50
Other Current Assets0.470.480.650.860.8936.18
Total Current Assets9.3710.6914.3517.1018.8852.82
Net Property, Plant & Equipment10.1210.4827.2810.9811.2811.53
Total Investments and Advances30.5731.527.1343.6742.867.11
Intangible Assets18.2318.5218.8019.0919.4120.34
Other Assets0.070.070.071.270.960.58
Total Assets68.3571.2767.6392.1293.3992.44
Short Term Debt Incl. Current Port. of LT Debt32.4832.3431.6444.8644.1747.47
Accounts Payable3.193.022.603.112.512.43
Other Current Liabilities13.5812.3213.256.237.154.15
Total Current Liabilities49.2447.6947.5054.1953.8354.05
Long Term Debt10.6611.0411.4211.8212.188.57
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities59.9058.7258.9166.0266.0262.61
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-0.383.38-0.8314.2015.6717.86
Total Shareholders Equity-0.383.38-0.8314.2015.6717.86
Accumulated Minority Interest8.839.179.5511.9011.7111.96
Total Equity8.4512.548.7126.1127.3829.82
Total Liabilities & Stockholders Equity68.3571.2767.6392.1293.3992.44
Book Value Per Share-0.040.34-0.091.561.721.96
Tangible Book Value Per Share-1.85-1.51-2.16-0.54-0.41-0.27
Full-Time Employees--102---
Price to Book Ratio-11.882.470.590.780.480.12
Return on Assets-34.19-30.56-27.54-35.85-37.90-39.52
Return on Equity-361.77-235.57-247.06-126.92-127.25-122.51
Return on Invested Capital-46.60-40.38-139.27-8.83-7.73-18.07
Quick Ratio0.150.190.260.260.300.93
Current Ratio0.190.220.300.320.350.98

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-4.91-6.35-17.40-2.19-2.61-5.30
Depreciation0.650.631.391.090.540.52
Other Funds (Non Cash)0.562.4110.97-1.641.453.20
Funds from Operations-3.70-3.31-5.04-2.74-0.62-1.57
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1.853.183.49-5.272.69-0.06
Cash from Operating Activities-1.85-0.13-1.55-8.012.07-1.64
Capital Expenditures-0.02-0.20-0.08-0.08-0.09-0.05
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.006.69-0.480.009.50
Purchase or Sale of Investments0.00-2.45-0.872.50-2.653.43
Purchase of Investments0.00-2.452.79-1.790.00-1.00
Sale Or Maturity of Investments0.000.00-3.664.30-2.654.43
Other Uses-0.05-0.000.000.000.000.00
Other Sources-0.000.010.250.000.000.00
Cash from Investing Activities-0.07-2.645.991.95-2.7412.88
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.700.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.700.000.000.000.00
Proceedsfrom Stock Options0.000.700.000.000.000.00
Issuance or Reduction of Debt, Net1.050.69-5.243.70-0.82-11.69
Change in Long Term Debt1.050.69-5.743.70-0.82-11.69
Issuance of Long Term Debt1.002.52-0.373.510.000.11
Reduction of Long Term Debt0.05-1.83-5.370.19-0.82-11.80
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities1.051.39-5.243.70-0.82-11.69
Net Change in Cash-0.87-1.38-0.81-2.37-1.49-0.46
Free Cash Flow-1.87-0.33-1.63-8.091.98-1.69

Revenue breakdown

Biotechnology2025: 38.00K
Commercial Lending2024: 226.00K 2025: 45.00K
Commission2024: 972.00K 2025: 1.35M
Printed Products2024: 16.11M 2025: 18.09M
Rental Income2024: 1.79M 2025: 1.24M
United States2024: 19.10M 2025: 20.76M
Biotechnology2025: 38.00K
Commercial Banking2024: 226.00K 2025: 45.00K
Product Packaging2024: 16.11M 2025: 18.15M
Securities2024: 2.76M 2025: 2.52M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.48%0.0M4.1M1.90M
2026-10-151.27%0.1M4.1M1.91M
2026-09-303.12%0.1M4.1M1.95M
2026-09-156.65%0.3M4.1M1.98M
2026-08-315.42%0.2M3.9M1.41M
2026-08-145.60%0.2M3.9M1.44M
2026-07-314.89%0.2M3.9M1.44M
2026-07-159.79%0.4M3.9M1.48M
2026-06-3011.73%0.5M3.9M1.45M
2026-06-1516.45%0.6M3.9M1.42M
2026-05-294.23%0.2M3.9M63.07K
2026-05-153.77%0.1M3.9M61.43K
2026-04-304.17%0.2M3.9M138.23K
2026-04-151.14%0.0M3.9M109.50K
2026-03-312.19%0.1M3.2M108.06K
2026-03-131.57%0.1M3.2M106.72K
2026-02-270.81%0.0M3.2M99.83K
2026-02-131.09%0.0M3.2M96.46K
2026-01-302.49%0.1M2.9M11.33K
2026-01-152.84%0.1M2.9M26.47K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-22PRE 14CInformation Statement Pursuant to Section 14(c) of the Securities Exchange Act of 19342026-10-22SEC
2026-10-20DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-10-20SEC
2026-09-244Statement of changes in beneficial ownership of securities2026-09-22SEC
2026-09-218-KCurrent report2026-09-15SEC
2026-09-08SCHEDULE 13D/ASEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-03SEC
2026-09-04424B5SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-09SCHEDULE 13D/ASEC
2026-07-094Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-258-KCurrent report2026-06-23SEC
2026-06-09RWRegistration Withdrawal RequestSEC
2026-05-1510-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-14DEF 14CInformation Statement Pursuant to Section 14(c) of the Securities Exchange Act of 19342026-05-14SEC
2026-04-24S-1/ASEC
2026-04-23PRE 14CInformation Statement Pursuant to Section 14(c) of the Securities Exchange Act of 19342026-04-22SEC
2026-04-17S-1General form of registration statement for all companies including face-amount certificate companiesSEC
2026-04-10DRSSEC
2026-03-318-KCurrent report2026-03-26SEC
2026-03-3110-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-02-17DEF 14CInformation Statement Pursuant to Section 14(c) of the Securities Exchange Act of 19342026-02-17SEC
2026-02-06PRER14CInformation Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934SEC
2026-02-058-KCurrent report2026-02-04SEC
2026-02-05424B5SEC
2026-01-14PRE 14CInformation Statement Pursuant to Section 14(c) of the Securities Exchange Act of 19342026-01-14SEC
2026-01-064Statement of changes in beneficial ownership of securities2025-05-22SEC
2025-12-058-KCurrent report2025-12-03SEC
2025-11-1410-QQuarterly report pursuant to Section 13 or 15(d)2025-09-30SEC
2025-10-21DEFR14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2025-10-20DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342025-10-20SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090017.92K1
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
HRT FINANCIAL LP2.08%
VANGUARD CAPITAL MANAGEMENT LLC0.58%
GEODE CAPITAL MANAGEMENT, LLC0.28%
RENAISSANCE TECHNOLOGIES LLC0.27%
BlackRock, Inc.0.21%
UBS Group AG0.17%
XTX Topco Ltd0.14%
Tower Research Capital LLC0.07%
VANGUARD FIDUCIARY TRUST CO0.07%
WELLS FARGO & COMPANY/MN0.00%

Funds

Fund% owned
VANGUARD EXTENDED MARKET INDEX FUND0.58%
Fidelity Extended Market Index Fund0.20%
Fidelity Series Total Market Index Fund0.05%
Fidelity Total Market Index Fund0.01%

OakChart. DSS. Cached 15 minutes.